Cardiorespiratory function and contractile reserve with aortic regurgitation after COVID-19 recovery

Authors: Glushko L.A., Mironenko M.Yu., Mironenko V.A., Averina I.I., Avakova S.A., Lisina M.O., Golukhova E.Z.

Company: Bakoulev National Medical Research Center for Cardiovascular of Surgery, Moscow, Russian Federation

For correspondence:  Sign in or register.

Type:  Original articles


DOI: https://doi.org/10.24022/1997-3187-2024-18-4-514-522

For citation: Glushko L.A., Mironenko M.Yu., Mironenko V.A., Averina I.I., Avakova S.A., Lisina M.O., Golukhova E.Z. Cardiorespiratory function and contractile reserve with aortic regurgitation after COVID-19 recovery. Creative Cardiology. 2024; 18(4): 514–522 (in Russ.). DOI: 10.24022/1997-3187-2024-18-4-514-522

Received / Accepted:  28.09.2024 / 12.11.2024

Keywords: COVID-19 cardiac function myocardial contractility aortic regurgitation cardiorespiratory function exercise tolerance pulmonary function

Download
Full text:  

 

Abstract

The aim of this study was to evaluate the impact of COVID-19 on the cardiorespiratory function and the contractile reserve of the heart in patients with aortic valve regurgitation during their recovery period.

Design of study – a single-center, retrospective study.

Material and methods. From January 2019 to August 2024, studies were conducted and data from 167 patients (89 men and 78 women) were analyzed within the group of pulmonary samples and gas exchange monitoring at the Bakoulev National Medical Research Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation. Patients were examined before the COVID-19 pandemic and in the recovery period. Patients underwent a comprehensive assessment of the cardiorespiratory system (computerized spirometry, assessment of lung diffusion capacity, cardiorespiratory stress testing, stress-echocardiography, including speckle-tracking stress-echocardiography) using Quark CPET (Cosmed, Italy), Ultima CardiO2 (Medical Graphics, USA), Epiq7 (Philips, Germany). The mean period after recovery from COVID-19 was 53.2 ± 3.4 days. The mean age of the patients was 45.4 ± 3.3 years.

Results. After the new coronavirus infection in patients with aortic regurgitation deterioration of cardiorespiratory function was noted. Statistically significant (p < 0.05) decrease of computerized spirometry data (forced expiratory volume in one second, forced vital capacity, maximum voluntary ventilation), decrease of lung diffusion capacity indices (lung diffusion capacity, corrected lung diffusion capacity, alveolar volume were registered. Statistically significant (p < 0.05) changes in cardiorespiratory function parameters were registered. Decrease in median peakVO2 (from 14.2 (12.6; 17.1) ml/kg/min to 11.1 (10.9;13.5) ml/kg/min reflected a decrease in the threshold of tolerance to physical load, increase in functional class of chronic heart failure (from 1.5 ± 0.2 to 2.9 ± 0.7). According to the data of stress-echocardiography there was an increase of aortic regurgitation degree from 1 to 2–3 degree, decrease of myocardial contractile reserve in the period of COVID-19 reconvalescence.

Conclusion. In order to detect severe aortic regurgitation to determine timely optimal tactics of treatment of COVID-19 deconditioned patients with aortic insufficiency, adequate prediction of risks of cardiorespiratory complications, a comprehensive assessment of the cardiorespiratory system is reasonable.

References

  1. Qiao J., Zhao P., Lu J., Huang L., Ma X., Zhou X., Xia L. Cardiac involvement in patients 1 year after recovery from moderate and severe COVID-19 infections. Front. Cardiovasc. Med. 2022; 9: 1009637. DOI: 10.3389/fcvm.2022.1009637
  2. Carfì A., Bernabei R., Landi F. Gemelli against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 11; 324 (6): 603–605. DOI: 10.1001/jama.2020.12603
  3. Wong A., Shah A., Johnston J., Carlsten C., Ryerson C. Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur. Respir. J. 2020; 56 (5): 2003276. DOI: 10.1183/13993003.03276-2020
  4. Kotova E.O., Pisaryuk A.S., Kobalava Zh.D., Timofeeva Yu.A., Chipigina N.S., Karaulova Yu.L., Ezhova L.G. Infectious endocarditis and COVID-19: an analysis of the influence of SARS-CoV-2 infection on the characteristics of diagnosis, course, prognosis. Russian Journal of Cardiology. 2023; 28 (1): 5229 (in Russ.). DOI: 10.15829/1560-4071-2023-5229
  5. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2003; 167: 211–277. DOI: 10.1164/rccm.167.2.211
  6. Sicari R., Nihoyannopoulos P., Evangelista A., Kasprzak J., Lancellotti P., Poldermans D. et al. European Association of Echocardiography. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur. J. Echocardiogr. 2008; 9 (4): 415–437. DOI: 10.1093/ejechocard/jen175
  7. Bockeria L.A., Bockeria O.L., Glushko L.A., Mironenko M.Yu., Donakanyan S.A., Biniashvili M.B. et al. Long-term results of state assessment of the cardiorespiratory system in patients with chronic ischemic heart disease after incomplete myocardial revascularization. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2019; 20 (7–8): 602–609 (in Russ.). DOI: 10.24022/1810-0694-2019-20-7-8-602-609
  8. Golukhova E.Z., Aslanidi I.P., Pursanova D.M., Mironenko V.A., Mironenko M.Yu., Thashokova L.R. Tissue Dopplerography and speckle- tracking echocardiography assessment of aortic biomechanics in aneurysms. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2023; 24 (4): 285–294 (in Russ.). DOI: 10.24022/1810-0694-2023-24-4-285-294
  9. Pelekh D.M., Nikitina T.G., Gulyan K.S., Filippkina T.Yu., Golukhova E.Z. Assessment of the quality of life in the medium-long-term after correction of valvular heart desease in old-aged patients.The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2023; 24 (2): 117–126 (in Russ.). DOI: 10.24022/1810-0694-2023-24-2-117-126
  10. Patsoeva I.M., Averina I.I., Mironenko M.Yu., Glushko L.A., Donakanyan S.A. Predictors of the development of heart failure after surgical correction of aortic regurgitation according to stress echocardiography. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2024; 25(1): 31–40 (in Russ.). DOI: 10.24022/1810-0694-2024-25-1-31-40
  11. Petrosyan K.V., Dadabaev G.M., Losev V.V., Petrosyan M.V. Transcatheter implantation of the valve-in-valve aortic valve against the background of destruction of a biological aortic prosthesis in a patient with high surgical risk. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2023; 24 (1): 79–86 (in Russ.). DOI: 10.24022/1810-0694-2023-24-1-79-86
  12. Patsoeva I.M., Averina I.I., Bockeria L.A. The role of stress echocardiography in predicting heart failure and determining surgical tactics in patients with aortic valve defects. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2022; 23 (1): 36–43 (in Russ.). DOI: 10.24022/1810-0694-2022-23-1-36-43
  13. Patsoeva I.M., Averina I.I., Mironenko M.Yu., Glushko L.A., Bockeria L.A. The use of stress echocardiography to predict heart failure in the postoperative period in patients with aortic insufficiency. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2022; 23 (2): 255–261 (in Russ.). DOI: 10.24022/1810-0694-2022-23-2-255-261
  14. Babeshko S.S., Barbukhatti K.O., Shumkov D.I., Kaleda V.I., Porkhanov V.A. Predictors of adverse outcomes in early and long-term dures after aortal valve replacement in patients with high disfunction of the left valve. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2024; 66 (2): 166–177 (in Russ.). DOI: 10.24022/0236-2791-2024-66-2-166-177
  15. Mazitova D.I., Zhbanov I.V., Shabalkin B.V. Remote results of surgical treatment of patients with ishemic heart disease and degenerative stenosis of aortal valve of different ages. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2024; 24 (2): 18
  16. Ermakov V.S., Kravchuk V.N., Porembskaya O.Ya., Shishkevich A.N. Early coronary altery bypass thrombosis after surgical myocardial revascularization in patients who underwent COVID-19. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2024; 66 (2): 192–200. DOI: 10.24022/0236-2791-2024-66-2-192-200

About Authors

  • Liudmila A. Glushko, Cand. Med. Sci., Chief of Group, Functional Diagnostician, Cardiologist, Associate Professor of Department; ORCID
  • Marina Yu. Mironenko, Cand. Med. Sci., Ultrasound Diagnostician, Head of Department, Associate Professor of the Department; ORCID
  • Vladimir A. Mironenko, Dr. Med. Sci., Professor, Head of Department, Cardiovascular Surgeon; ORCID
  • Irina I. Averina, Dr. Med. Sci., Senior Researcher; ORCID
  • Susanna A. Avakova, Cand. Med. Sci., Head of Department;
  • Marina O. Lisina, Cand. Med. Sci., Researcher;
  • Elena Z. Golukhova, Dr. Med. Sci., Professor, Academician of the Russian Academy of Sciences, Director of the Center, Head of the Department; ORCID

Chief Editor

Elena Z. Golukhova, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, Director of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by